Singapore ingredient maker Avant has unleashed Zellulin BioPlatform, a range of skin care actives made from cultivated marine cells.
Zellulin BioPlatform involves the sustainable replication of functional proteins from cultivated marine cells, and the transformation of these proteins into nature-balanced biopeptide complexes with comprehensive skin care benefits.
Avant says its patented Zellulin Bioplatform offers a revolutionary approach to peptide production.
“By utilizing cultivated marine cells, we can now produce cell-identical proteins and peptides, yielding precisely what cells produce for their optimal function,” said a spokeswoman.
“This breakthrough enables the creation of sustainable, nature-balanced biopeptide complexes with unparalleled skin-loving benefits,” she added.
The first Zellulin Bioplatform product, ZelluGEN, is an extracellular matrix (ECM) targeted regenerative peptide complex for the skin.
It is claimed to instruct skin cells to generate more ECM, including collagen, integrin and fibrinogen.
In a single-blind, placebo-controlled efficacy study of an eye cream containing 1% Zellulin ZelluGEN active, results showed statistically significant benefits: increases skin hydration, firmness and elasticity; maintains skin barrier; and promotes skin collagen production.
In a consumer perception blind test of a face cream containing 1% Zellulin ZelluGEN active: 64% of the respondents saw a significant improvement in their skin appearance within 14 days; 82% of the respondents are interested in buying the product after knowing the technology; 92% of the respondents are open to using the product containing ingredients derived from fish cells manufactured responsibly and cruelty-free.
"The Zellulin BioPlatform represents a paradigm shift in skin care technology," said Carrie Chan, CEO of Avant.
"By harnessing the power of nature and biotechnology, we are able to deliver skincare ingredients that not only address the signs of ageing on a cellular level but also adhere to our commitment to sustainability and traceability," she added.
